{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:37:12Z","timestamp":1793288232227,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.arteri.2014.07.003","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T20:05:25Z","timestamp":1414008325000},"page":"296-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Effects of thyroid hormones on the heart"],"prefix":"10.1016","volume":"26","author":[{"given":"Hernando","family":"Vargas-Uricoechea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anilsa","family":"Bonelo-Perdomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Hern\u00e1n","family":"Sierra-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2014.07.003_bib0005","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1210\/en.2008-1795","article-title":"Minireview: thyrotropin-releasing hormone and the thyroid hormone feedback mechanism","volume":"150","author":"Chiamolera","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.arteri.2014.07.003_bib0010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.physiol.62.1.439","article-title":"The mechanism of action of thyroid hormones","volume":"62","author":"Zhang","year":"2000","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.arteri.2014.07.003_bib0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/edrv.23.1.0455","article-title":"Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases","volume":"23","author":"Bianco","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arteri.2014.07.003_bib0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/JOE-12-0258","article-title":"Iodothyronine deiodinases: a functional and evolutionary perspective","volume":"215","author":"Orozco","year":"2012","journal-title":"J Endocrinol"},{"key":"10.1016\/j.arteri.2014.07.003_bib0025","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1016\/j.bbagen.2012.05.007","article-title":"The deiodinases and the control of intracellular thyroid hormone signaling during cellular differentiation","volume":"1830","author":"Dentice","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arteri.2014.07.003_bib0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/JOE-10-0481","article-title":"Deiodinases: the balance of thyroid hormone Type 1 iodothyronine deiodinase in human physiology and disease","volume":"209","author":"Maia","year":"2011","journal-title":"J Endocrinol"},{"key":"10.1016\/j.arteri.2014.07.003_bib0035","doi-asserted-by":"crossref","first-page":"e52407","DOI":"10.1371\/journal.pone.0052407","article-title":"Gene specific actions of thyroid hormone receptor subtypes","volume":"8","author":"Lin","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.arteri.2014.07.003_bib0040","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1016\/j.bbagen.2012.06.003","article-title":"Thyroid hormone receptors: the challenge of elucidating isotype-specific functions and cell-specific response","volume":"1830","author":"Flamant","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arteri.2014.07.003_bib0045","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1016\/j.bbagen.2012.07.001","article-title":"The in vivo role of nuclear receptor corepressors in thyroid hormone action","volume":"1830","author":"Astapova","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl. 5","key":"10.1016\/j.arteri.2014.07.003_bib0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000110469","article-title":"Thyroid hormone transporters","volume":"68","author":"Visser","year":"2007","journal-title":"Horm Res"},{"key":"10.1016\/j.arteri.2014.07.003_bib0055","first-page":"26","article-title":"Cracking the code for thyroid hormone signaling","volume":"124","author":"Bianco","year":"2013","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.arteri.2014.07.003_bib0060","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-13-0573","article-title":"Thyroid: biological actions of \u2018nonclassical\u2019 thyroid hormones","volume":"221","author":"Senese","year":"2014","journal-title":"J Endocrinol"},{"key":"10.1016\/j.arteri.2014.07.003_bib0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1515\/hmbci-2013-0059","article-title":"Thyroid hormones and the heart","volume":"18","author":"Vargas-Uricoechea","year":"2014","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.arteri.2014.07.003_bib0070","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/er.2003-0033","article-title":"Thyroid hormone action in the heart","volume":"26","author":"Kahaly","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arteri.2014.07.003_bib0075","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.arteri.2014.07.003_bib0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/heart.84.4.455","article-title":"Thyroid disease and the heart","volume":"84","author":"Toft","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.arteri.2014.07.003_bib0085","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1210\/jcem.87.3.8302","article-title":"Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism","volume":"87","author":"Biondi","year":"2002","journal-title":"JCEM"},{"key":"10.1016\/j.arteri.2014.07.003_bib0090","article-title":"Thyroid and the heart","volume":"March","author":"Grais","year":"2014","journal-title":"Am J Med"},{"issue":"Suppl.","key":"10.1016\/j.arteri.2014.07.003_bib0095","first-page":"26","article-title":"Thyrotoxicosis","volume":"59","author":"Sahay","year":"2011","journal-title":"JAPI"},{"key":"10.1016\/j.arteri.2014.07.003_bib0100","first-page":"5170","article-title":"Thyrotoxic cardiac disease","author":"Dahl","year":"2008","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.arteri.2014.07.003_bib0105","first-page":"62","article-title":"Heart disease in patients with thyroid dysfunction: hyperthyroidism, hypothyroidism and beyond","volume":"13","author":"Coceani","year":"2013","journal-title":"Anadolu Kardiyol Derg"},{"key":"10.1016\/j.arteri.2014.07.003_bib0110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.2009.0272","article-title":"Thyroid function and left ventricular structure and function in the Framingham Heart Study","volume":"20","author":"Pearce","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.arteri.2014.07.003_bib0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1871530311313010005","article-title":"Thyroid disorders in chronic heart failure: from prognostic set-up to therapeutic management","volume":"13","author":"Triggiani","year":"2013","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.arteri.2014.07.003_bib0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.14310\/horm.2002.1158","article-title":"Normalization of thyroid hormone levels in patients with either hyper- or hypothyroidism results in a profound change of atrial natriuretic peptide (ANP) levels","volume":"1","author":"Koukoulis","year":"2002","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.arteri.2014.07.003_bib0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/EJE-07-0357","article-title":"Changes in heart rate variability and QT dispersion in patients with overt hypothyroidism","volume":"158","author":"Galetta","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arteri.2014.07.003_bib0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1210\/rp.59.1.31","article-title":"Effects of thyroid hormone on the cardiovascular system","volume":"59","author":"Fazio","year":"2004","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.arteri.2014.07.003_bib0135","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1210\/jc.2004-1554","article-title":"The association of thyroid function with cardiac mass and left ventricular hypertrophy","volume":"90","author":"Dorr","year":"2005","journal-title":"JCEM"},{"key":"10.1016\/j.arteri.2014.07.003_bib0140","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11906-003-0060-7","article-title":"Thyroid hormone and blood pressure regulation","volume":"5","author":"Danzi","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.arteri.2014.07.003_bib0145","doi-asserted-by":"crossref","first-page":"374","DOI":"10.5603\/CJ.2012.0068","article-title":"Evaluation of left ventricular systolic asynchrony in patients with subclinical hypothyroidism","volume":"19","author":"Ozturk","year":"2012","journal-title":"Cardiol J"},{"key":"10.1016\/j.arteri.2014.07.003_bib0150","series-title":"The heart, arteries and veins","first-page":"1907","article-title":"The heart and endocrine disease","author":"Zonstein","year":"1994"},{"key":"10.1016\/j.arteri.2014.07.003_bib0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000313464","article-title":"Link between pericardial effusion and attenuation of QRS voltage in patients with hypothyroidism","volume":"116","author":"Yamanaka","year":"2010","journal-title":"Cardiology"},{"key":"10.1016\/j.arteri.2014.07.003_bib0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2012.10.070","article-title":"Carotid intima-media thickness in patients with subclinical hypothyroidism: a meta-analysis","volume":"227","author":"Gao","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2014.07.003_bib0165","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/EJE-12-0627","article-title":"Heart failure and thyroid dysfunction","author":"Biondi","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arteri.2014.07.003_bib0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10741-008-9126-6","article-title":"The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence","author":"Galli","year":"2010","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.arteri.2014.07.003_bib0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/vhrm.1.2.97.64076","article-title":"Thyroid (dys) function in heart failure: is it a potential target for medical treatment?","volume":"1","author":"Pingitore","year":"2005","journal-title":"Vasc Health Risk Manage"},{"key":"10.1016\/j.arteri.2014.07.003_bib0180","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejim.2012.12.004","article-title":"Thyroid hormones and erythrocyte indices in a cohort of euthyroid older subjects","volume":"24","author":"Schindhelm","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.arteri.2014.07.003_bib0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11897-009-0035-3","article-title":"Tachycardia-mediated cardiomyopathy: recognition and management","volume":"6","author":"Gopinathannair","year":"2009","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.arteri.2014.07.003_bib0190","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein","year":"2001","journal-title":"NEJM"},{"key":"10.1016\/j.arteri.2014.07.003_bib0195","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/hrt.2006.100628","article-title":"Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with hyperthyroidism","volume":"93","author":"Siu","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.arteri.2014.07.003_bib0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4158\/EP.9.2.140","article-title":"Severe reversible dilated cardiomyopathy and hyperthyroidism: case report and review of the literature","volume":"9","author":"Boccalandro","year":"2003","journal-title":"Endocr Pract"},{"key":"10.1016\/j.arteri.2014.07.003_bib0205","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1210\/jc.2013-1039","article-title":"Subclinical hypothyroidism and survival: the effects of heart failure and race","volume":"98","author":"Rhee","year":"2013","journal-title":"JCEM"},{"key":"10.1016\/j.arteri.2014.07.003_bib0210","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/CIRCULATIONAHA.109.917922","article-title":"Thyroid replacement therapy and heart failure","volume":"122","author":"Gerdes","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.arteri.2014.07.003_bib0215","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1756-6614-6-2","article-title":"Managing thyroid dysfunction in selected special situations","volume":"6","author":"Sabih","year":"2013","journal-title":"Thyroid Res"},{"key":"10.1016\/j.arteri.2014.07.003_bib0220","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/187153012799278947","article-title":"Incidence and prevalence of hypothyroidism in patients affected by chronic heart failure: role of amiodarone","volume":"12","author":"Triggiani","year":"2012","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.arteri.2014.07.003_bib0225","doi-asserted-by":"crossref","first-page":"e7895","DOI":"10.1136\/bmj.e7895","article-title":"The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study","volume":"345","author":"Selmer","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.arteri.2014.07.003_bib0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1756-6614-2-4","article-title":"The mechanisms of atrial fibrillation in hyperthyroidism","volume":"2","author":"Bielecka-Dabrowa","year":"2009","journal-title":"Thyroid Res"},{"key":"10.1016\/j.arteri.2014.07.003_bib0235","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrendo.2010.105","article-title":"Cardiovascular involvement in patients with different causes of hyperthyroidism","volume":"6","author":"Biondi","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arteri.2014.07.003_bib0240","first-page":"225","article-title":"Embolic risk in atrial fibrillation that arises from hyperthyroidism. Review of the medical literature","volume":"38","author":"Traube","year":"2011","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.arteri.2014.07.003_bib0245","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5603\/CJ.2011.0022","article-title":"Short-term outcome of early electrical cardioversion for atrial fibrillation in hyperthyroid versus euthyroid patients","volume":"19","author":"Ari","year":"2012","journal-title":"Cardiol J"},{"key":"10.1016\/j.arteri.2014.07.003_bib0250","first-page":"623","article-title":"Risk assessment in the development of atrial fibrillation at patients with associate thyroid dysfunctions","volume":"117","author":"T\u0103nase","year":"2013","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"10.1016\/j.arteri.2014.07.003_bib0255","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJM200107263450406","article-title":"Clinical practice. Subclinical hypothyroidism","volume":"345","author":"Cooper","year":"2001","journal-title":"NEJM"},{"key":"10.1016\/j.arteri.2014.07.003_bib0260","doi-asserted-by":"crossref","first-page":"127","DOI":"10.15208\/mhsj.2010.124","article-title":"Heart rate variability indicators in patients with hypothyroidism","volume":"6","author":"Moldabek","year":"2011","journal-title":"MHSJ"},{"key":"10.1016\/j.arteri.2014.07.003_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12011","article-title":"The thyroid \u2013 too much and too little across the ages. The consequences of subclinical thyroid dysfunction","volume":"78","author":"Franklyn","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arteri.2014.07.003_bib0270","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.beem.2011.12.004","article-title":"Natural history, diagnosis and management of subclinical thyroid dysfunction","volume":"26","author":"Biondi","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.arteri.2014.07.003_bib0275","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.arteri.2014.07.003_bib0280","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1210\/jc.2013-1875","article-title":"Subclinical hypothyroidism and cardiovascular risk: how to end the controversy","volume":"98","author":"Rodondi","year":"2013","journal-title":"JCEM"},{"key":"10.1016\/j.arteri.2014.07.003_bib0285","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical hyperthyroidism and the risk of coronary heart disease and mortality","volume":"172","author":"Collet","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.arteri.2014.07.003_bib0290","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1871530311313010003","article-title":"Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies","volume":"13","author":"Gencer","year":"2013","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.arteri.2014.07.003_bib0295","first-page":"340","article-title":"Amiodarone and the thyroid: a 2012 update","volume":"35","author":"Bogazzi","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.arteri.2014.07.003_bib0300","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2009.225","article-title":"Effects of amiodarone therapy on thyroid function","volume":"6","author":"Cohen-Lehman","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arteri.2014.07.003_bib0305","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SMJ.0b013e3181e90500","article-title":"Amiodarone and thyroid dysfunction","volume":"103","author":"Padmanabhan","year":"2010","journal-title":"South Med J"},{"key":"10.1016\/j.arteri.2014.07.003_bib0310","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/MED.0b013e3283565bb2","article-title":"Iodine-induced thyroid dysfunction","volume":"19","author":"Leung","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.arteri.2014.07.003_bib0315","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.beem.2009.07.001","article-title":"Amiodarone and thyroid","volume":"23","author":"Eskes","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.arteri.2014.07.003_bib0320","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone induced thyrotoxicosis","volume":"95","author":"Bogazzi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arteri.2014.07.003_bib0325","first-page":"47","article-title":"The cardiology and endocrinology connection between amiodarone and thyrotoxicosis: case report and review of the literature","volume":"105","author":"Palermo-Gar\u00f3falo","year":"2013","journal-title":"Bol Asoc Med P R"},{"key":"10.1016\/j.arteri.2014.07.003_bib0330","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1540-8167.2010.01764.x","article-title":"A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study","volume":"21","author":"Le Heuzey","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.arteri.2014.07.003_bib0335","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa054686","article-title":"Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter","volume":"357","author":"Singh","year":"2007","journal-title":"NEJM"},{"key":"10.1016\/j.arteri.2014.07.003_bib0340","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1517\/14740330903514105","article-title":"Efficacy and safety of dronedarone: a review of randomized trials","volume":"9","author":"Christiansen","year":"2010","journal-title":"Expert Opin Drug Saf"}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916814001181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916814001181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T08:04:34Z","timestamp":1717488274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916814001181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0214916814001181"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2014.07.003","relation":{},"ISSN":["0214-9168"],"issn-type":[{"value":"0214-9168","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of thyroid hormones on the heart","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2014.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}